LungLife AI, INC 10 February 2025 10 February 2025 LungLife AI, Inc. (the "Company" or "LungLife") Change of Nominated Adviser and Joint...
LungLife AI Inc shares collapsed on Monday as it said it would seek shareholder approval to leave the AIM market and ...
LungLife AI, INC 03 February 2025 This announcement contains inside information as stipulated under the UK version of the Market Abuse...
LungLife AI, INC 19 November 2024 LungLife AI, Inc. (the "Company" or "LungLife") Operational update Strong progress towards...
LungLife AI, INC 15 November 2024 LungLife AI, Inc. (the "Company" or "LungLife") Block Listing Six Monthly Return LungLife AI (AIM:...
LungLife AI, INC 25 October 2024 LungLife AI, Inc. (the "Company" or "LungLife") Directorate Change LungLife AI (AIM: LLAI), a developer...
LungLife AI, INC 22 October 2024 22 October 2024 LungLife AI, Inc ("LungLife" or the "Company") Cancellation and Reissue of Share Options /...
LungLife AI, INC 04 October 2024 LungLife AI, Inc. (the "Company" or "LungLife") Options Cancellation and Re-issuance LungLife AI (AIM:...
LungLife AI, INC 02 October 2024 LungLife AI, Inc. (the "Company" or "LungLife") LungLB® analytical validation accepted for publication in...
LungLife AI, INC 02 September 2024 LungLife AI, Inc. (the "Company" or "LungLife") Data Supporting LungLB to be Presented at the...
California-based developer of clinical diagnostic solutions for lung cancer - Pretax loss narrows 34% to USD1.9 milli ...
LungLife AI, INC 22 August 2024 LungLife AI, Inc. (the "Company" or "LungLife") Half-year Report LungLife AI (AIM: LLAI), a developer...
LungLife AI Inc on Friday shared positive news for its LungLB test, which is designed to deliver information to clini ...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads